Gallium [68Ga] Natan recombinant PD-L1 single domain antibody

镓[68Ga]纳坦重组PD-L1单域抗体

Report date: 2025/09/22 17:57:07

Base Information

Drug NameGallium [68Ga] Natan recombinant PD-L1 single domain antibody

Drug Alias NameSNA002 PD-L1 imagingSNA-00268Ga-NOTA-SNA002

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)Diagnostic agent (In vivo) > Radionuclide Imaging agent +[6]

Mechanisms of ActionAnti-Programmed death-ligand 1Radionuclide imaging enhancers

TargetsProgrammed death-ligand 1

Therapy Area/IndicationsContrast agentsSolid tumoursNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesSmartnuclide Biopharma

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesSmartnuclide Biopharma

Inactive CompaniesN/A

Active IndicationsContrast agentsSolid tumoursNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A